- |||||||||| Bivalent RBD-based ARVAC-CG vaccine / National University of San Martin, National Scientific and Technical Research Council, Pablo Cassara, Omicron Variant RBD-based ARVAC-CG vaccine / National University of San Martin, National Scientific and Technical Research Council, Pablo Cassara, Gamma Variant RBD-based ARVAC-CG vaccine / National University of San Martin, National Scientific and Technical Research Council, Pablo Cassara
New P2/3 trial: ARVAC-F2/3-002: ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine (clinicaltrials.gov) - Mar 2, 2023
P2/3, N=2014, Recruiting,
- |||||||||| Coronavirus Vaccine / National University of San Martin, National Scientific and Technical Research Council
Journal: COVID-19 vaccination certificates and lifting public health and social measures: ethical considerations. (Pubmed Central) - Jul 12, 2022
Vaccination certificates may undermine a population-based approach to COVID-19 vaccination to achieve and accelerate universal lifting of PHSMs, result in unfair and inequitable health and social outcomes, and generate social divisions at a time when solidarity within (and between) countries is necessary to navigate the pandemic and its burdens. Further research on the ethical acceptability and impact of COVID-19 vaccine certificates in countries that have implemented them should be carried out to inform future ethical considerations on this issue.
|
